Fredun Pharmaceuticals Ltd (FREDUN) — concall transcript | 31 March 2026
Fredun Pharmaceuticals reported 27.27% YoY revenue growth to INR213 crores in Q4 FY26 and 40.08% YoY growth to INR639.12 crores for FY26, driven by hormonal, anti-aging, mobility, and pet care segments. Management highlighted plans to launch medicated hormone products via doctor channels and online platforms, exclusive NAD+ API imports, and expansion of pet care with 42 functional food variants and diagnostics. The company targets 25-30% revenue growth in FY27, 10-12% PAT margins, and aims for 50-70% contribution from new-age businesses within 2-3 years. It plans to add 12-13 packing lines by September and expand manufacturing capacity, supported by strong order backlogs and improved cash flow.
About Fredun Pharmaceuticals Ltd (FREDUN)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when FREDUN files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track FREDUN — Free💡 Ask AI about this filing
📊 More FREDUN filings
- 🟡 Board Meeting — 16 September 2026 On September 16, 2026, Fredun Pharmaceuticals' board allotted 271,200 equity shares of Rs 10 each to...
- 🔴 Corporate Action — 16 September 2026 Fredun Pharmaceuticals allotted 271,200 equity shares of Rs 10 each to non-promoter warrant holders ...
- 🔴 Announcement — 15 September 2026 Fredun Pharmaceuticals announced that its pet wellness brand Furlicks expanded from 6 to 22 SKUs, ac...
- 🔴 Announcement — 15 September 2026 Fredun Pharmaceuticals announced that its pet wellness brand Furlicks expanded from 6 to 22 SKUs, ac...
- 🔴 Announcement — 8 September 2026 Fredun Pharmaceuticals announced its acquisition of Furlicks, a pet-wellness brand specializing in o...
🔥 Also filed on 31 March 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when FREDUN files new disclosures
Track FREDUN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FREDUN — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd